Navigation Links
Vital step in cellular migration described by UCSD medical researchers

A vital molecular step in cell migration, the movement of cells within the body during growth, tissue repair and the body's immune response to invading pathogens, has been demonstrated by researchers in the University of California, San Diego (UCSD) School of Medicine. Published in the March 27 online edition of Nature Cell Biology and the journal's upcoming April print edition, the study describes how a the interaction of alpha4 integrin adhesion receptor with a protein called paxillin creates directional movement of a cell by inhibiting a protein called Rac.

"Understanding how this protein contributes to directional movement of a cell provides a new insight into cell migration and ultimately could lead to therapeutic interventions in autoimmune diseases such as multiple sclerosis and Crohn's disease," said the paper's first author Naoyuki Nishiya, Ph.D., a postgraduate researcher in the lab of senior author Mark Ginsberg, M.D., UCSD professor of medicine. "Since cell migration plays an important role in the immune response, as leukocytes move toward targets, a therapy that stops that movement could potentially help in autoimmune disorders where the body's immune system incorrectly attacks the body's own tissue."

From the genesis of human life to birth and beyond, cell migration is a complex, extremely important process that is not completely understood by researchers. In order to move, a cell must be polarized so that the molecular processes at the front end and back end are different, leading only to forward movement. One of the first steps in cell migration is the initiation of activity by Rac that extends protrusions out of the cell. These protrusions serve as tractor sites for migration as the cell moves toward its intended target. If Rac were active throughout the cell, it would extend protrusions in all directions, in essence keeping the cell in one place.

Until now, researchers have had limited understanding of the molecular mechanism
'"/>

Source:University of California - San Diego


Page: 1 2

Related biology news :

1. Vital ocean prey play active role in environment
2. Scientists discover the cellular roots of graying hair
3. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
4. New study to explore cellular circuitry
5. Study provides insight into cellular defenses against genetic mutation
6. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level
7. Liver cancer linked to cellular repair pathway
8. New cellular flaw found in some virulent breast cancers
9. Insects that produce males from unfertilized eggs reveal a surprising cellular feat
10. University of Minnesota researchers take new look at cellular suicide
11. RNA found in the cellular centrosome of surf clams
Post Your Comments:
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/23/2015)... , June 23, 2015   MedNet Solutions ... supports the entire spectrum of clinical research, is ... ™ , the company,s intuitive, flexible and ... a Silver 2015 Stevie® Award by the ... & Services Website category.  The American Business Awards ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... CORVALLIS, Ore. A laboratory study has shown for the ... are linked to a side-effect of some statin drugs - ... of the most widely prescribed drugs in the world, able ... of heart attacks or other cardiovascular events. However, their role ...
... dozen Ludwig scientists from around the world presented the ... this week,s American Association for Cancer Research (AACR) Annual ... program with important diagnostic and treatment implications for emerging ... available to help patients with melanoma, researchers are developing ...
... age at which a child with autism is diagnosed ... he or she exhibits, new research from the University ... poor nonverbal communication and repetitive behaviors, were associated with ... a study in the April issue of the ...
Cached Biology News:Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes 2Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting 2In autism, age at diagnosis depends on specific symptoms 2
(Date:7/1/2015)... TRIANGLE PARK, N.C. and ... agricultural research firm AgBiome, and Genective, key developer ... to accelerate the discovery of new generations of ... traits for insect control to counter the realities ... partner with Genective, aligning AgBiome,s unique insect control ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
(Date:7/1/2015)... 2015 InferMed , ... will augment ... clinical s olutions suite   Elsevier ... products and services, announced today the acquisition of  InferMed , ... technology company. InferMed,s Arezzo technology supports clinicians in ...
(Date:6/30/2015)... Japan , July 1, 2015 R-Japan Co.,Ltd. ... on the Safety of Regenerative Medicine from the Ministry of ... on June 29, 2015. The fact that ... processing facility through the auditing from Pharmaceuticals and Medical Devices ... the application, allows it to provide stem cell manufacturing service ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2
... , PALO ALTO, Calif., Aug. 17, 2009 ... with a focus on the NS4B Hepatitis C Virus (HCV) ... Board of Directors. , , Truex is ... private pharmaceutical company focused on the development of anti-inflammatory products ...
... , SAN DIEGO, Aug. 17 Imagenetix, ... natural-based, proprietary products announced that last week Dr. Robert Hesslink, ... on his Bloomberg Radio program, Taking Stock. Dr. Hesslink ... its flagship product, InflameAway Celadrin(R), and 1-TDC, Imagenetix,s early stage ...
... Inc. (NASDAQ: VSGN ; TSX:VAS), today announced that ... Department of The NASDAQ Stock Market indicating that Vasogen ... We plan to request a hearing before the NASDAQ ... determination of the continued listing of our common stock. ...
Cached Biology Technology:Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors 2Imagenetix, Inc. Announces Interview With Bloomberg Radio 2Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 2